Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials

Published:2015-03-18 Issue:6 Volume:61 Page:1798-1808
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Younossi Zobair M.¹²,Stepanova Maria³²,Marcellin Patrick⁴,Afdhal Nezam⁵,Kowdley Kris V.⁶,Zeuzem Stefan⁷,Hunt Sharon L.²

Affiliation:

1. Center for Liver Diseases, Department of Medicine; Inova Fairfax Hospital; Falls Church VA

2. Betty and Guy Beatty Center for Integrated Research; Inova Health System; Falls Church VA

3. CLDQ LLC; Washington DC

4. Viral Hepatitis Research Unit in Hôpital Beaujon; Clichy France

5. Hepatology, Beth Israel Deaconess Medical Center; Boston MA

6. Liver Care Network and Organ Care Research; Swedish Medical Center; Seattle WA

7. Department of Medicine; J.W. Goethe University Hospital; Frankfurt Germany

Funder

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27724/fullpdf

Reference49 articles.

1. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality;Mühlberger;BMC Public Health,2009

2. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection;Kanwal;Gastroenterology,2011

3. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression;Davis;Gastroenterology,2010

4. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications;Benvegnù;Gut,2004

5. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients;Sangiovanni;Hepatology,2006

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should they wait? Two children under 3 years old infected by HCV 1b successfully treated by ledipasvir/sofosbuvir: A report of two cases;Liver Research;2023-12

2. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review;Gastroenterología y Hepatología;2023-05

3. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review;Gastroenterología y Hepatología (English Edition);2023-05

4. Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2022-12-02

5. Hepatitis C Virus Infections in Patients with Hemophilia: Links, Risks and Management;Journal of Multidisciplinary Healthcare;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3